Polar Capital Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.8M | Buy |
70,000
+15,000
| +27% | +$7.88M | 0.19% | 104 |
|
|
2025
Q1 | $34.9M | Sell |
55,000
-1,249
| -2% | -$792K | 0.21% | 115 |
|
|
2024
Q4 | $40.1M | Sell |
56,249
-15,546
| -22% | -$11.1M | 0.22% | 111 |
|
|
2024
Q3 | $75.5M | Sell |
71,795
-61,236
| -46% | -$64.4M | 0.36% | 62 |
|
|
2024
Q2 | $140M | Sell |
133,031
-43,927
| -25% | -$46.2M | 0.82% | 31 |
|
|
2024
Q1 | $170M | Sell |
176,958
-20,889
| -11% | -$20.1M | 0.89% | 26 |
|
|
2023
Q4 | $174M | Buy |
197,847
+65,347
| +49% | +$57.4M | 1.06% | 16 |
|
|
2023
Q3 | $109M | Hold |
132,500
| – | – | 0.81% | 30 |
|
|
2023
Q2 | $95.2M | Hold |
132,500
| – | – | 0.48% | 43 |
|
|
2023
Q1 | $109M | Buy |
132,500
+15,000
| +13% | +$12.3M | 0.71% | 34 |
|
|
2022
Q4 | $84.8M | Buy |
117,500
+5,000
| +4% | +$3.61M | 0.68% | 43 |
|
|
2022
Q3 | $77.5K | Sell |
112,500
-12,500
| -10% | -$8.61K | 0.49% | 51 |
|
|
2022
Q2 | $73.9K | Sell |
125,000
-20,000
| -14% | -$11.8K | 0.43% | 59 |
|
|
2022
Q1 | $101K | Sell |
145,000
-25,000
| -15% | -$17.5K | 0.46% | 44 |
|
|
2021
Q4 | $107K | Hold |
170,000
| – | – | 0.4% | 46 |
|
|
2021
Q3 | $103K | Buy |
170,000
+20,000
| +13% | +$12.1K | 0.42% | 47 |
|
|
2021
Q2 | $83.8K | Buy |
150,000
+75,000
| +100% | +$41.9K | 0.36% | 64 |
|
|
2021
Q1 | $35.5M | Sell |
75,000
-20,000
| -21% | -$9.46M | 0.22% | 115 |
|
|
2020
Q4 | $45.9M | Buy |
+95,000
| New | +$45.9M | 0.28% | 100 |
|